MARKET

CLYM

CLYM

Climb Bio
NASDAQ
1.350
+0.020
+1.50%
After Hours: 1.330 -0.02 -1.48% 19:31 03/14 EDT
OPEN
1.340
PREV CLOSE
1.330
HIGH
1.375
LOW
1.310
VOLUME
120.36K
TURNOVER
--
52 WEEK HIGH
11.55
52 WEEK LOW
1.200
MARKET CAP
90.86M
P/E (TTM)
-0.6323
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CLYM last week (0303-0307)?
Weekly Report · 6d ago
Weekly Report: what happened at CLYM last week (0224-0228)?
Weekly Report · 03/03 10:14
Top-rated biotechs with negative enterprise values
Seeking Alpha · 03/01 19:28
Climb Bio appoints Perrin Wilson as CBO
TipRanks · 02/24 12:30
CLIMB BIO APPOINTS PERRIN WILSON, PH.D., AS CHIEF BUSINESS OFFICER
Reuters · 02/24 12:00
*Climb Bio: Appoints Perrin Wilson as Chief Business Officer >CLYM
Dow Jones · 02/24 12:00
Press Release: Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
Dow Jones · 02/24 12:00
Weekly Report: what happened at CLYM last week (0217-0221)?
Weekly Report · 02/24 10:14
More
About CLYM
Climb Bio, Inc., formerly Eliem Therapeutics, Inc., is a clinical-stage biotechnology company. The Company is focused on developing therapeutics for patients with immune-mediated diseases. The Company’s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in Phase I clinical trial.

Webull offers Climb Bio Inc stock information, including NASDAQ: CLYM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLYM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLYM stock methods without spending real money on the virtual paper trading platform.